MAIA
MAIA Biotechnology reports that 150 patients have been treated with ateganosine sequenced with a checkpoint inhibitor across its ongoing THIO-101 Phase 2 and THIO-104 Phase 3 trials. Part C of THIO-101 is fully enrolled, THIO-104 has 65 patients enrolled toward a 100-patient year-end target, and the company cites a 90.5% interim disease control rate for the combination in an efficacy-evaluable population.
SLE
Super League published a letter from CEO Matt Edelman explaining the proposed transaction with Metaplanet Inc. and why management believes the deal would add a Bitcoin treasury and a new strategic scale while retaining the company’s gaming advertising business. Stockholder approval at the 2026 Annual Meeting on October 16, 2026 and other closing conditions remain required for the transaction to close.
BKV
BKV Corporation says a wholly owned subsidiary executed an equipment supply contract for natural gas-fired power generation equipment for a prospective Texas project, with a backstop agreement from a leading investment-grade hyperscaler that covers approximately 90% of payments owed through March 31, 2027. The supplier is to deliver approximately 1,200 megawatts of equipment beginning in September 2028.
MARKET NEWS
Caribou Biosciences (CRBU) experienced a ~35% after‑hours drop with no accompanying company announcement or earnings; separately, CRH announced it will acquire aggregate operations in Denmark and Finland.
EGY
Vaalco reported completion of its offshore Gabon Phase 3 drilling program with the ETSEM-3H well now on production and the drilling rig demobilized. The company also said Baobab Phase 5 drilling has begun offshore Côte d’Ivoire, with a first new producer anticipated online near the end of 2026 and production growth expected in 2027.
ASYS
Amtech Systems, Inc. (NASDAQ: ASYS) will present at the LD Micro Main Event XX investor conference on October 20, 2026 in Los Angeles, giving an investor presentation at 3:30 PM PST and hosting one-on-one meetings. The company said the presentation will be posted on its investor relations website the morning of the event and the session will be webcast.
CRH
CRH announced it has signed an agreement to acquire NCC Industry’s operations in Denmark and Finland. The deal is described as expanding CRH’s aggregates footprint in the Nordics and remains subject to approvals, with completion expected during 2027.
GNS
Genius Group announced it recommenced Bitcoin treasury purchases, acquiring 10 Bitcoin for approximately $854,000 at an average price of $85,364 per BTC between October 2 and October 5, 2026. The purchases form part of a Board-approved $1.2 billion dual treasury capital plan allocating $827 million to Bitcoin and $800 million to AI assets by FY2031.
PTHS
Pelthos Therapeutics said it reached a PBM agreement adding 24 million covered lives and a regional health plan update covering approximately 3 million lives, bringing ZELSUVMI formulary coverage to 127 million commercially covered lives. The company reiterated that ZELSUVMI is approved for adults and pediatric patients one year of age and older and highlighted safety and prescribing information in the release.
MARKET NEWS
Confirmed: Paramount has completed its acquisition of Warner Bros. Discovery and the companies will form a new combined entertainment company called Skydance (ticker: SKYD). The item is listed as an acquisition and flagged high importance in the news digest — deal news is currently driving the tape.
MARKET NEWS
Major U.S. ETFs finished Tuesday nearly unchanged, while activity was concentrated in smaller stocks and individual movers. Options trading in the major ETFs remained balanced, leaving the broader market without a strong directional signal into Wednesday.
AMD
AMD announced it will report fiscal third quarter 2026 financial results on Tuesday, Nov. 3, 2026, after the market close, and will host a conference call at 5 p.m. ET / 2 p.m. PT. The company also disclosed upcoming investor events at the UBS Global Technology and AI Conference on Tuesday, Dec. 1, 2026, and the Barclays 24 th Annual Global Technology Conference on Wednesday, Dec. 9, 2026.
BFRG
BullFrog AI says it has achieved key project milestones with a top 5 global pharmaceutical company, reporting that its AI platform identified and prioritized novel therapeutic targets for major depressive disorder. The company also highlights broader programs applying its platform to schizophrenia, bipolar disorder, and other therapeutic areas.
STZ
Constellation Brands announced its second quarter fiscal 2027 financial results and scheduled a conference call for October 7, 2026 at 8:00 a.m. ET. The company published a PDF with the quarter's financial results and tables and described its global beverage alcohol business and brands.
APLD
Applied Digital announced an agreement providing access to up to 1 gigawatt (GW) of potential power capacity in Finland and said this represents its first development opportunity outside of the United States. The company plans a large-scale AI Factory campus with initial power availability anticipated beginning in 2028 and will advance development tied to customer demand and regulatory milestones.
VUZI
Vuzix Corporation announced a partnership with Shiny Box Interactive to develop military medical training and remote-mentoring solutions for the Vuzix Ultralite Pro OEM Platform, building on prior deployments using Vuzix M400, M4000 and Blade 2 smart glasses. The collaboration targets hands-free, see-through wearable applications for austere and contested environments, and is positioned for defense and tactical use cases.
OSTX
OS Therapies reported a final three-year overall survival rate of 72.7 percent for OST-HER2 (Herlystic™)–treated patients versus 45.8 percent in a combined historical control (p = 0.0006) from its Phase 2b pulmonary metastatic osteosarcoma program. The company says it is preparing regulatory submissions in multiple jurisdictions and plans a Phase 3 CTA to the U.K. MHRA as a precursor to trial initiation.
CNXU
Conexeu Sciences reports progress on manufacturing scale-up, preclinical testing, and regulatory preparations for a planned FDA 510(k) premarket notification for Ten Minute Tissue™ with an intended submission in the first quarter of 2027. The company says multiple scaled-up batches met predefined specifications and that it has engaged the FDA through the Q-Submission process.
ICCM
IceCure Medical announced that Legacy Health’s Legacy Medical Group–Surgical Oncology at Good Samaritan Medical Center has joined the company’s ChoICE post-market study of ProSense® cryoablation for low-risk breast cancer. The company says the FDA-approved study is expected to enroll approximately 400 patients across up to 30 U.S. sites and names Dr. Nathalie Johnson as a co-primary investigator for the Legacy site.
SCYX
SCYNEXIS reported completion of a Phase 1 study of SCY-770, an oral direct AMPK activator, in healthy adults. The company said SCY-770 was well tolerated across dose cohorts and that a Phase 2 proof-of-concept study in ADPKD patients remains on-track to initiate in the fourth quarter of 2026.
VKTX
Viking Therapeutics initiated Part 2 of a two-part maintenance study of VK2735 to explore oral and additional subcutaneous maintenance regimens following an initial 21-week induction with weekly subcutaneous dosing. The randomized, double-blind, placebo-controlled study will enroll approximately 195 adults with obesity and assess safety, tolerability, pharmacokinetics, and exploratory weight-change endpoints through Week 33.
CLNE
Clean Energy Fuels Corp. named JJ Armstrong as Chief Financial Officer effective immediately, succeeding Robert Vreeland. Armstrong has been with Clean Energy since 2014 and previously worked 11 years at EY; the company framed the move as part of its continued focus on growth and execution.
MARKET NEWS
Fathom Holdings and Neighborhood Intelligence mutually terminated their proposed merger, according to a company announcement dated October 5. The development is a company-specific catalyst for FTHM and removes the proposed transaction from the near-term story.
MARKET NEWS
What happened: Fathom Holdings (FTHM) and Neighborhood Intelligence mutually terminated their proposed merger (published Oct 5). Why it matters: a confirmed deal termination is a discrete corporate event for FTHM that traders may treat as a catalyst. Market context: overnight regime is neutral, small-cap momentum is active, and options flow flags bullish call activity in SPCX, SPY and NVDA — but several data confirmations are degraded or stale.
ONDS
Ondas Inc. announced a $56 million order for Electronic Safe & Arm Devices (ESADs) to support a European loitering munition program, the company said on October 5, 2026. The order was secured through Bron Technologies and is described as the first ESAD order since Ondas' acquisitions of GATE Technologies and Bron Technologies.
MARKET NEWS
Fathom Holdings and Neighborhood Intelligence mutually ended their proposed merger (news published Oct 5). Market-level context: overnight regime neutral, small-cap momentum active, and options flow shows bullish call activity concentrated in SPCX and SPY. Key dealer/gamma reads for SPY and QQQ are in negative-gamma regimes.
NEO
NeoGenomics announced a planned leadership transition effective January 4, 2027, naming Warren Stone CEO and Tony Zook Executive Chairman, with related Board changes. The company also provided preliminary, unaudited third quarter results and said preliminary third quarter total revenue was expected to be approximately $209 million with NGS revenue growth of approximately 28%, and indicated an expected increase to full year total revenue guidance at the midpoint.
MARKET NEWS
Fathom Holdings (FTHM) and Neighborhood Intelligence mutually terminated their proposed merger (announced 2026-10-05). Below: the core fact, exact source timing, and concise market context from SMC snapshots (after‑hours overview, options flow, GEX data).
FRMM
Forum Markets formed Forum Edge AI LLC with Edge Node AI to own and operate inference GPU compute at powered data sites and mobile communications towers. The initial planned deployment comprises approximately 11 MW of energized capacity, and Forum introduced full-year 2027 consolidated revenue guidance of $125 Million to $175 Million.
MARKET NEWS
Fathom Holdings (FTHM) and Neighborhood Intelligence announced a mutual termination of their proposed merger (news published 2026-10-05 07:01 ET). Market context: after-hours regime is neutral, small-cap momentum and breakouts are active; options flow shows bullish call activity concentrated in QQQ and SPY. Data feeds show several freshness and trust warnings — see caveats.
